Scilex Holding Company (NASDAQ: SCLXW) Stock Competitors & Peer Comparison
See SCLXW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SCLXW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SCLXW | $0.16 | -6.12% | 44.7M | N/A | -$32.57 | N/A |
| LLY | $1,225.73 | +3.60% | 1.2T | 38.95 | $31.49 | +0.55% |
| JNJ | $271.11 | +3.33% | 653.4B | 25.27 | $10.73 | +1.94% |
| ABBV | $258.92 | +3.43% | 457.5B | 25.41 | $10.19 | +2.65% |
| MRK | $135.18 | -0.58% | 333.8B | 42.11 | $3.21 | +2.48% |
| NVS | $154.55 | +1.70% | 293.9B | 17.79 | $8.69 | +3.06% |
| AZN | $160.10 | +2.05% | 248.3B | 17.29 | $9.26 | +1.30% |
| AMGN | $425.28 | +1.41% | 229.5B | 19.01 | $22.37 | +2.30% |
| NVO | $45.71 | +1.85% | 202.9B | 11.37 | $4.02 | +2.54% |
| GILD | $143.44 | +3.25% | 178.1B | -367.79 | -$0.39 | +2.25% |
Stock Comparison
Eli Lilly and Company (NYSE: LLY)
SCLXW vs LLY Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, LLY has a market cap of 1.2T. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while LLY trades at $1,225.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas LLY's P/E ratio is 38.95. In terms of profitability, SCLXW's ROE is +1.90%, compared to LLY's ROE of +0.93%. Regarding short-term risk, SCLXW is more volatile compared to LLY. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check LLY's competition here
Johnson & Johnson (NYSE: JNJ)
SCLXW vs JNJ Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, JNJ has a market cap of 653.4B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while JNJ trades at $271.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas JNJ's P/E ratio is 25.27. In terms of profitability, SCLXW's ROE is +1.90%, compared to JNJ's ROE of +0.26%. Regarding short-term risk, SCLXW is more volatile compared to JNJ. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check JNJ's competition here
AbbVie Inc. (NYSE: ABBV)
SCLXW vs ABBV Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, ABBV has a market cap of 457.5B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while ABBV trades at $258.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas ABBV's P/E ratio is 25.41. In terms of profitability, SCLXW's ROE is +1.90%, compared to ABBV's ROE of -1.36%. Regarding short-term risk, SCLXW is more volatile compared to ABBV. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check ABBV's competition here
Merck & Co., Inc. (NYSE: MRK)
SCLXW vs MRK Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, MRK has a market cap of 333.8B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while MRK trades at $135.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas MRK's P/E ratio is 42.11. In terms of profitability, SCLXW's ROE is +1.90%, compared to MRK's ROE of +0.07%. Regarding short-term risk, SCLXW is more volatile compared to MRK. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check MRK's competition here
Novartis AG (NYSE: NVS)
SCLXW vs NVS Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, NVS has a market cap of 293.9B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while NVS trades at $154.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas NVS's P/E ratio is 17.79. In terms of profitability, SCLXW's ROE is +1.90%, compared to NVS's ROE of +0.30%. Regarding short-term risk, SCLXW is more volatile compared to NVS. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check NVS's competition here
AstraZeneca PLC (NYSE: AZN)
SCLXW vs AZN Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, AZN has a market cap of 248.3B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while AZN trades at $160.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas AZN's P/E ratio is 17.29. In terms of profitability, SCLXW's ROE is +1.90%, compared to AZN's ROE of +0.22%. Regarding short-term risk, SCLXW is more volatile compared to AZN. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check AZN's competition here
Amgen Inc. (NASDAQ: AMGN)
SCLXW vs AMGN Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, AMGN has a market cap of 229.5B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while AMGN trades at $425.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas AMGN's P/E ratio is 19.01. In terms of profitability, SCLXW's ROE is +1.90%, compared to AMGN's ROE of +0.89%. Regarding short-term risk, SCLXW is more volatile compared to AMGN. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check AMGN's competition here
Novo Nordisk A/S (NYSE: NVO)
SCLXW vs NVO Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, NVO has a market cap of 202.9B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while NVO trades at $45.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas NVO's P/E ratio is 11.37. In terms of profitability, SCLXW's ROE is +1.90%, compared to NVO's ROE of +0.59%. Regarding short-term risk, SCLXW is more volatile compared to NVO. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check NVO's competition here
Gilead Sciences, Inc. (NASDAQ: GILD)
SCLXW vs GILD Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, GILD has a market cap of 178.1B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while GILD trades at $143.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas GILD's P/E ratio is -367.79. In terms of profitability, SCLXW's ROE is +1.90%, compared to GILD's ROE of -0.16%. Regarding short-term risk, SCLXW is more volatile compared to GILD. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check GILD's competition here
Pfizer Inc. (NYSE: PFE)
SCLXW vs PFE Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, PFE has a market cap of 155.4B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while PFE trades at $27.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas PFE's P/E ratio is 8.94. In terms of profitability, SCLXW's ROE is +1.90%, compared to PFE's ROE of +0.05%. Regarding short-term risk, SCLXW is more volatile compared to PFE. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check PFE's competition here
Bristol-Myers Squibb Company (NYSE: BMY)
SCLXW vs BMY Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, BMY has a market cap of 132.1B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while BMY trades at $66.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas BMY's P/E ratio is 10.90. In terms of profitability, SCLXW's ROE is +1.90%, compared to BMY's ROE of +0.47%. Regarding short-term risk, SCLXW is more volatile compared to BMY. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check BMY's competition here
Sanofi (NASDAQ: SNY)
SCLXW vs SNY Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, SNY has a market cap of 108B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while SNY trades at $44.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas SNY's P/E ratio is 9.80. In terms of profitability, SCLXW's ROE is +1.90%, compared to SNY's ROE of +0.06%. Regarding short-term risk, SCLXW is more volatile compared to SNY. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check SNY's competition here
GSK plc (NYSE: GSK)
SCLXW vs GSK Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, GSK has a market cap of 102.5B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while GSK trades at $51.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas GSK's P/E ratio is 11.05. In terms of profitability, SCLXW's ROE is +1.90%, compared to GSK's ROE of +0.24%. Regarding short-term risk, SCLXW is more volatile compared to GSK. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check GSK's competition here
Zoetis Inc. (NYSE: ZTS)
SCLXW vs ZTS Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, ZTS has a market cap of 31B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while ZTS trades at $73.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas ZTS's P/E ratio is 11.24. In terms of profitability, SCLXW's ROE is +1.90%, compared to ZTS's ROE of +0.69%. Regarding short-term risk, SCLXW is more volatile compared to ZTS. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check ZTS's competition here
Biogen Inc. (NASDAQ: BIIB)
SCLXW vs BIIB Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, BIIB has a market cap of 30.9B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while BIIB trades at $212.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas BIIB's P/E ratio is 13.20. In terms of profitability, SCLXW's ROE is +1.90%, compared to BIIB's ROE of +0.05%. Regarding short-term risk, SCLXW is more volatile compared to BIIB. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check BIIB's competition here
Horizon Therapeutics Public Limited Company (NASDAQ: HZNP)
SCLXW vs HZNP Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, HZNP has a market cap of 26.6B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while HZNP trades at $116.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas HZNP's P/E ratio is 61.86. In terms of profitability, SCLXW's ROE is +1.90%, compared to HZNP's ROE of +0.11%. Regarding short-term risk, SCLXW is more volatile compared to HZNP. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check HZNP's competition here
Grifols, S.A. (NASDAQ: GRFS)
SCLXW vs GRFS Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, GRFS has a market cap of 6.6B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while GRFS trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas GRFS's P/E ratio is 8.90. In terms of profitability, SCLXW's ROE is +1.90%, compared to GRFS's ROE of +0.08%. Regarding short-term risk, SCLXW is more volatile compared to GRFS. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check GRFS's competition here
Organon & Co. (NYSE: OGN)
SCLXW vs OGN Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, OGN has a market cap of 3.6B. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while OGN trades at $13.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas OGN's P/E ratio is 4.08. In terms of profitability, SCLXW's ROE is +1.90%, compared to OGN's ROE of +0.23%. Regarding short-term risk, SCLXW is more volatile compared to OGN. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check OGN's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
SCLXW vs CELG-RI Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, CELG-RI has a market cap of 224.5M. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while CELG-RI trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, SCLXW's ROE is +1.90%, compared to CELG-RI's ROE of N/A. Regarding short-term risk, SCLXW is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check CELG-RI's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
SCLXW vs CTOR Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, CTOR has a market cap of 67M. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while CTOR trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas CTOR's P/E ratio is -1.53. In terms of profitability, SCLXW's ROE is +1.90%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, SCLXW is more volatile compared to CTOR. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check CTOR's competition here
Scilex Holding Company (NASDAQ: SCLX)
SCLXW vs SCLX Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, SCLX has a market cap of 53.8M. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while SCLX trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas SCLX's P/E ratio is -0.16. In terms of profitability, SCLXW's ROE is +1.90%, compared to SCLX's ROE of +1.90%. Regarding short-term risk, SCLXW is more volatile compared to SCLX. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check SCLX's competition here
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA)
SCLXW vs MIRA Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, MIRA has a market cap of 32.1M. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while MIRA trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas MIRA's P/E ratio is -0.53. In terms of profitability, SCLXW's ROE is +1.90%, compared to MIRA's ROE of -1.07%. Regarding short-term risk, SCLXW is more volatile compared to MIRA. This indicates higher risk in terms of short-term price fluctuations for SCLXW.Check MIRA's competition here
Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT)
SCLXW vs CRXT Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, CRXT has a market cap of 0. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while CRXT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas CRXT's P/E ratio is -0.02. In terms of profitability, SCLXW's ROE is +1.90%, compared to CRXT's ROE of -4.63%. Regarding short-term risk, SCLXW is less volatile compared to CRXT. This indicates lower risk in terms of short-term price fluctuations for SCLXW.Check CRXT's competition here
BioDelivery Sciences Intl, Inc. Wrrt (NASDAQ: BDSIW)
SCLXW vs BDSIW Comparison August 2026
Scilex Holding Company (NASDAQ: SCLXW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SCLXW stands at 44.7M. In comparison, BDSIW has a market cap of 0. Regarding current trading prices, SCLXW is priced at $0.16 on the NASDAQ, while BDSIW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SCLXW currently has a P/E ratio of N/A, whereas BDSIW's P/E ratio is -0.43. In terms of profitability, SCLXW's ROE is +1.90%, compared to BDSIW's ROE of +0.57%. Regarding short-term risk, SCLXW is less volatile compared to BDSIW. This indicates lower risk in terms of short-term price fluctuations for SCLXW.Check BDSIW's competition here